NV

Nicki Vasquez

Actinogen Medical Limited | Non-Executive Director
Dr Vasquez is a biopharmaceutical executive with more than 30 years of biopharmaceutical discovery research and development experience. Dr Vasquez most recently served as Chief Portfolio Strategy & Alliance Officer at Sutro Biopharma, a clinical stage oncology company in San Francisco where she was responsible for program management, portfolio strategy, and alliance management. Prior to joining Sutro, Dr Vasquez was Vice President of Program & Portfolio Management at StemCells, Inc., where she was responsible for establishing project management of research and clinical stage programs exploring stem cell therapy for Alzheimer's disease, spinal cord injury and dry Age-related Macular Degeneration. Earlier in her career Dr Vasquez worked at Elan Pharmaceuticals where she held positions of increasing responsibility in Alzheimer's disease and autoimmune discovery research, to Vice President Research Operations & Program Management, and Vice President Development Program & Portfolio Management.

Company and Role

Company
Title
Tenure
Since
ACW
Actinogen Medical Limited
  • Non-Executive Director
3yrs, 4mthMar 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ACW
Actinogen Medical Limited
24/06/2610,948,724N/A183,334N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ACW
Actinogen Medical Limited
24/06/26
Issued
3,000,000$0.046$136,500Issued under employee share plan
ACW
Actinogen Medical Limited
26/03/26
Issued
82,057$0.042$3,446Placement
ACW
Actinogen Medical Limited
24/03/25
Issued
2,000,000$0.043$85,000Issued under employee share plan
ACW
Actinogen Medical Limited
05/06/24
Issued
366,667$0.025$9,166Rights issue
ACW
Actinogen Medical Limited
05/06/24
Issued
183,334$0.029$5,316Rights issue